Further studies on lidoflazine (R-7904).
D000109:Acetylcholine / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D001920:Bradykinin / Q000494:pharmacology; D002415:Cats; D003864:Depression, Chemical; D005260:Female; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006168:Guinea Pigs; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D008688:Methacholine Compounds / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects*; D010879:Piperazines / Q000494:pharmacology*; D011448:Prostaglandin Antagonists; D051381:Rats; D012702:Serotonin Antagonists; D013270:Stomach / Q000187:drug effects; D014599:Uterus / Q000187:drug effects
D006634:Histamine H1 Antagonists; D008688:Methacholine Compounds; D010879:Piperazines; D011448:Prostaglandin Antagonists; D012702:Serotonin Antagonists; D000804:Angiotensin II; D000109:Acetylcholine; D001920:Bradykinin